Cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | ||
==External links== | ==External links== | ||
| Line 31: | Line 26: | ||
{{Circulatory system pathology}} | {{Circulatory system pathology}} | ||
[[de:Kardiomyopathie]] | [[de:Kardiomyopathie]] | ||
| Line 47: | Line 41: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Genetic Disease]] | [[Category:Genetic Disease]] | ||
[[Category: Up-To-Date]] | |||
[[Category: Up-To-Date Cardiology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 17:19, 16 October 2011
For patient information click here
| Cardiomyopathy | |
 | |
|---|---|
| Opened left ventricle of heart shows a thickened, dilated left ventricle with subendocardial fibrosis manifested as increased whiteness of endocardium {Autopsy findings}. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.0 |
| ICD-9 | 425.4 |
| DiseasesDB | 2137 |
| MeSH | D009202 |
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
External links
- The Cardiomyopathy Association
- Cardiomyopathy information from Seattle Children's Hospital Heart Center
- Information from the Stanford Hypertrophic Cardiomyopathy Center
- Cardiomyopathy-related antibodies
de:Kardiomyopathie nl:Cardiomyopathie no:Kardiomyopati simple:Cardiomyopathy sr:Кардиомиопатија sv:Hjärtmuskelsjukdom